Life-Sciences-Benelux.com
The Benelux Life Sciences Web Portal

This is a free web portal for the life sciences in Belgium, The Netherlands and Luxembourg... » read more

Peter Halle Joins BGV as Venture Partner from Merck KGaA (2024-04-02)
BioGeneration Ventures ("BGV"), a leading early-stage VC firm specializing in European biopharma, is delighted to announce the appointment of Dr. Joern-Peter Halle as Venture Partner further enriching the company's team, network and expertise in company establishme...
NewAmsterdam Pharma Appoints Juliette Audet as CBO (2024-04-01)
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density l...
TNO Spins Off Peregrion to Market AMS Mass Spec Technology (2024-03-25)
TNO spin-off Peregrion brings science to the marketplace Ten years of development at TNO, the largest independent research and technology organisation in the Netherlands and one of the largest in the EU, has yielded a track record and acceptance by regulators ...
Investor David Lazar Acquires Control over OpGen/Curetis (2024-03-25)
> David Lazar invests $3 million in Preferred Stock > New OpGen Board of Directors appointed > David Lazar will take over as CEO of OpGen > OpGen settles outstanding liabilities with EIB OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), an...
Angelini Ventures Adds €7m to Series C of Nouscom (2024-03-21)
> Angelini Ventures joins syndicate of top-tier international healthcare investors in Nouscom’s Series C financing round > Financing will enable Nouscom to continue advancing the clinical development of its portfolio of neoantigen cancer vaccines to key clinic...
BioNTech Appoints Annemarie Hanekamp as CCO (2024-03-20)
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that the Supervisory Board has appointed Annemarie Hanekamp to the Management Board as Chief Commercial Officer effective July 1, 2024. She will join BioNTech from Novartis AG (“Novar...
Capstan Therapeutics Closes $175m Series B Financing (2024-03-20)
> Financing syndicate led by RA Capital Management includes new investors Forbion, Johnson & Johnson Innovation – JJDC, Mubadala Capital, Perceptive Advisors, and Sofinnova Investments > Financing supports advancement of CPTX2309, Capstan’s lead in vivo CAR-...
Engrail Therapeutics Closes Oversubscribed $157m Series B (2024-03-19)
Proceeds to Support Advancement of Engrail’s Pipeline for Neuropsychiatric and Neurodevelopmental Disorder Engrail Therapeutics™ (Engrail) (the Company), a precision neuroscience company focused on the development of transformational therapies to improve t...
Medios to Acquire Ceban Pharma for €259.2m in Cash & Shares (2024-03-18)
Important first step in building the leading European Specialty Pharma platform – Mid-term targets to be reached already in 2025 Medios, the leading provider of Specialty Pharma Solutions in Germany, today announced the acquisition of Ceban Pharmaceuticals B...
Alithea Genomics Closes CHF 2.8m Seed Financing Extension (2024-03-14)
Proceeds to launch new RNA sequencing products, expand production capacity, develop new technologies and open US subsidiary. Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of a C...

Life-Sciences-Benelux.com is your doorway to the Benelux life sciences!

[LSBNL] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Benelux countries Belgium, The Netherlands and Luxembourg.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSBNL] is 100% Made in Germany!

» Start here with the latest News!

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)